ASX
Paradigm Biopharmaceuticals
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm Receives $7.36m R&D Tax Incentive Refund
Published: 07/02/24, 09:14am (AEST)•1 pages